Loss of integrin alpha1beta1 ameliorates Kras-induced lung cancer

Ines Macias-Perez1, Corina Borza, Xiwu Chen

  • 1Department of Medicine, Division of Nephrology, Vanderbilt University Medical Center, Veterans Affairs Hospital, Nashville, Tennessee 37232, USA.

Cancer Research
|August 5, 2008
PubMed

Insights

Integrin alpha1beta1 promotes non-small cell lung cancer growth. Loss of integrin alpha1 reduces lung tumor incidence and progression in Kras-driven mouse models, indicating a cooperative role in cancer development.

Area of Science:

  • Oncology
  • Cell Biology
  • Molecular Biology

Background:

  • Integrin alpha1beta1, a collagen IV binding receptor, is implicated in lung cancer via proangiogenic effects.
  • Its direct role in primary lung tumor promotion remains largely uncharacterized.

Purpose of the Study:

  • To investigate the direct role of integrin alpha1beta1 in promoting primary lung tumors initiated by oncogenic Kras.
  • To elucidate the molecular mechanisms underlying integrin alpha1's function in non-small cell lung cancer (NSCLC) development.

Main Methods:

  • Crossed integrin alpha1-null mice with KrasLA2 mice (carrying oncogenic Kras G12D mutation) to generate KrasLA2/alpha1-null and control littermates.
  • Assessed tumor incidence, survival, vascularization, proliferation (PCNA), apoptosis (TUNEL), and kinase activation (ERK, p38 MAPK).
  • Evaluated anchorage-independent colony formation, collagen-mediated proliferation, ERK activation, and tumorigenicity of isolated tumor cells in vivo.

Main Results:

  • KrasLA2/alpha1-null mice exhibited decreased primary lung tumor incidence and prolonged survival compared to controls.
  • Tumors in KrasLA2/alpha1-null mice were smaller, less vascularized, with reduced proliferation and increased apoptosis.
  • Loss of integrin alpha1 diminished ERK activation but enhanced p38 MAPK activation, and reduced tumor cell tumorigenicity and proliferation.

Conclusions:

  • Loss of the integrin alpha1 subunit significantly decreases the incidence and growth of lung epithelial tumors initiated by oncogenic Kras.
  • Integrin alpha1beta1 and oncogenic Kras cooperate to drive the progression of non-small cell lung cancer in vivo.
  • Targeting integrin alpha1beta1 may represent a therapeutic strategy for NSCLC.

Related Concept Videos

Intracellular Signaling Affects Focal Adhesions01:17

Intracellular Signaling Affects Focal Adhesions

Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Activation of Integrins01:15

Activation of Integrins

Integrins bind ligands and transmit information from outside the cell to inside or vice-versa through an "outside-in signaling" or "inside-out signaling."
In "outside-in signaling," external factors in the extracellular space bind to exposed ligand binding sites on integrins. This causes the inactive protein to undergo a conformational change to become active. Integrins are often clustered on the cell membrane. Repetitive and regularly spaced ligand binding events provide an effective stimulus.
Integrins01:10

Integrins

Animal and protozoan cells do not have cell walls to help maintain shape and provide structural stability. Instead, these eukaryotic cells secrete a sticky mass of carbohydrates and proteins into the spaces between adjacent cells. This network of proteins and molecules is called an extracellular matrix or ECM.
Some ECM proteins assemble into a basement membrane to which the remaining components adhere. Proteoglycans typically form the bulk of the ECM while fibrous proteins, like collagen,...
The Ras Gene02:38

The Ras Gene

The Ras-gene-encoded proteins are regulators of signaling pathways controlling cell proliferation, differentiation, or cell survival. The Ras-gene family in humans constitutes three primary members—the HRas, NRas, and KRas. These genes code for four functionally distinct yet closely related proteins—the HRas, NRas, KRas4A, and KRas4B. The involvement of mutant Ras genes in human cancer was first discovered in 1982 and is among the most common causes of human tumorigenesis.
Ras is a superfamily...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: